These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12151116)

  • 1. The interface of preclinical evaluation with clinical testing of antiepileptic drugs: role of pharmacogenomics and pharmacogenetics.
    Holmes GL
    Epilepsy Res; 2002 Jun; 50(1-2):41-54. PubMed ID: 12151116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics and antiepileptic drugs.
    Spear BB
    Epilepsia; 2001; 42 Suppl 5():31-4. PubMed ID: 11887965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs.
    Anderson GD
    Ther Drug Monit; 2008 Apr; 30(2):173-80. PubMed ID: 18367977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on pharmacogenetics in epilepsy: a brief review.
    Szoeke CE; Newton M; Wood JM; Goldstein D; Berkovic SF; OBrien TJ; Sheffield LJ
    Lancet Neurol; 2006 Feb; 5(2):189-96. PubMed ID: 16426995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Pharmacogenomics in Antiepileptic Drug Therapy: Current Status and Future Perspectives.
    Gambardella A; Labate A; Mumoli L; Lopes-Cendes I; Cendes F
    Curr Pharm Des; 2017; 23(37):5760-5765. PubMed ID: 28891449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Various pharmacogenetic aspects of antiepileptic drug therapy: a review.
    Mann MW; Pons G
    CNS Drugs; 2007; 21(2):143-64. PubMed ID: 17284096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacogenetics, pharmacogenomics and individualised antiepileptic therapy].
    Herranz JL
    Rev Neurol; 2006 Oct; 43 Suppl 1():S43-9. PubMed ID: 17061195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs.
    Piana C; Antunes Nde J; Della Pasqua O
    Expert Opin Drug Metab Toxicol; 2014 Mar; 10(3):341-58. PubMed ID: 24460510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications.
    Depondt C; Shorvon SD
    Pharmacogenomics; 2006 Jul; 7(5):731-45. PubMed ID: 16886898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics and epilepsy: the road ahead.
    Cavalleri GL; McCormack M; Alhusaini S; Chaila E; Delanty N
    Pharmacogenomics; 2011 Oct; 12(10):1429-47. PubMed ID: 22008048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of pharmacogenetics in the treatment of epilepsy.
    Depondt C
    Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacogenomics of epilepsy.
    Franco V; Perucca E
    Expert Rev Neurother; 2015 Oct; 15(10):1161-70. PubMed ID: 26327193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical re-evaluation of previous preclinical strategies for the discovery and the development of new antiepileptic drugs.
    Löscher W; Leppik IE
    Epilepsy Res; 2002 Jun; 50(1-2):17-20. PubMed ID: 12151113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics in the treatment of epilepsy.
    Clancy CE; Kass RS
    Pharmacogenomics; 2003 Nov; 4(6):747-51. PubMed ID: 14596638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics in epilepsy.
    Balestrini S; Sisodiya SM
    Neurosci Lett; 2018 Feb; 667():27-39. PubMed ID: 28082152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical reappraisal of the influence of drug-transporter polymorphisms in epilepsy.
    Orlandi A; Paolino MC; Striano P; Parisi P
    Expert Opin Drug Metab Toxicol; 2018 May; 14(5):505-512. PubMed ID: 29804481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs.
    Rogawski MA
    Epilepsia; 2013 May; 54 Suppl 2():33-40. PubMed ID: 23646969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.
    Seo T; Ishitsu T; Ueda N; Nakada N; Yurube K; Ueda K; Nakagawa K
    Pharmacogenomics; 2006 Jun; 7(4):551-61. PubMed ID: 16753003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Personalized medicine for epilepsy based on the pharmacogenomic testing].
    Yoshida S; Sugawara T; Nishio T; Kaneko S
    Brain Nerve; 2011 Apr; 63(4):295-9. PubMed ID: 21441631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The new antiepileptic drugs: their indications and side effects].
    Malagón-Valdez J
    Rev Neurol; 2004 Sep 16-30; 39(6):570-5. PubMed ID: 15467997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.